Daxocox is a new Non Steroidal Anti-Inflammatory Drug (NSAID) containing enflicoxib that has recently received a positive opinion for marketing authorisation. Medications like this are used to reduce inflammation and so cause pain relief in effected animals. Daxocox in particular is indicated for the treatment of pain and inflammation associated with osteoarthritis (or degenerative joint disease) in dogs.

There are many other NSAID medications on the market, such as meloxicam. Daxocox will be a great addition to the veterinary arsenal to control pain associated with arthritis and other diseases.

The product has only just received a positive opinion for initial marketing on the 17th February 2021 so it will be a while before it is released onto the veterinary market. We will provide more information on the product when it becomes available.

If you have any specific questions regarding Credelio Plus please contact our customer services on [email protected].

Written by: Dr. Nick Garside BVetMed MRCVS